CLINICAL_TRIALS
trial_result
· 2009-03-20
Clinical Trial Update: Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan [Phase 2]
Summary
Phase 2 trial of bupropion sustained-release in Japanese patients with major depressive disorder completed; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Major Depressive Disorder (MDD) | Phase 2 | Status: COMPLETED | Results posted: 2009-03-20